For some patients with peripheral artery disease, exercise can be impractical or impossible. Could the glucagon-like peptide-1 (GLP-1) agonists offer new hope for restoring movement and quality of life?
Guest Authors: Minitha Jacob, PharmD and Sherry Laguardia, PharmD, BCACP
Special Guest: Kristin Watson, PharmD, BCCP
Music by Good Talk

For some patients with peripheral artery disease, exercise can be impractical or impossible. Could the glucagon-like peptide-1 (GLP-1) agonists offer new hope for restoring movement and quality of life? Guest Authors: Minitha Jacob, PharmD and Sherry Laguardia, PharmD, BCACP Special Guest: Kristin Watson, PharmD, BCCP Music by Good Talk

Making STRIDEs: GLP-1s Walk the Line in Peripheral Artery Disease

We explore the evidence that informs ambulatory care pharmacy practice. Check out our website &amp; podcasts, &amp; consider submitting a commentary!

Medicine

Health & Fitness

We explore the evidence that informs ambulatory care pharmacy practice. Check out our website & podcasts, & consider submitting a commentary!

Share Making STRIDEs: GLP-1s Walk the Line in Peripheral Artery Disease

Sign up to save your podcasts

Making STRIDEs: GLP-1s Walk the Line in Peripheral Artery Disease

Making STRIDEs: GLP-1s Walk the Line in Peripheral Artery Disease